PLGA/mesoporous silica hybrid structure for controlled drug release
- 1 August 2004
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 98 (2), 209-217
- https://doi.org/10.1016/j.jconrel.2004.04.023
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A New Property of MCM-41: Drug Delivery SystemChemistry of Materials, 2000
- In vitro evaluation of biodegradable ε-caprolactone-co-d,l-lactide/silica xerogel composites containing toremifene citrateInternational Journal of Pharmaceutics, 1999
- Nonionic Triblock and Star Diblock Copolymer and Oligomeric Surfactant Syntheses of Highly Ordered, Hydrothermally Stable, Mesoporous Silica StructuresJournal of the American Chemical Society, 1998
- Triblock Copolymer Syntheses of Mesoporous Silica with Periodic 50 to 300 Angstrom PoresScience, 1998
- Antibiotic delivery system using bioactive bone cement consisting of Bis-GMA/TEGDMA resin and bioactive glass ceramicsBiomaterials, 1997
- Synthesis of ceramic-polymer-drug biocomposites at room temperatureSolid State Ionics, 1997
- Ibuprofen release from hydrophilic ceramic-polymer compositesBiomaterials, 1997
- Cisplatin-loaded poly (methyl methacrylate) implants: a sustained drug delivery systemJournal of Controlled Release, 1995
- Bioceramics: From Concept to ClinicJournal of the American Ceramic Society, 1991
- Synthesis and fabrication of ?-tricalcium phosphate (whitlockite) ceramics for potential prosthetic applicationsJournal of Materials Science, 1979